Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 3Phase 2 2Phase 3 1

Status

Completed 4Recruiting 3Active not recruiting 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Liver Neoplasms 1Glioblastoma 1Carcinoma, Hepatocellular 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

pembrolizumab 86Cyclophosphamide 75Nivolumab 55Specimen Handling 49fludarabine 48Magnetic Resonance Spectroscopy 44Carboplatin 41Biopsy 39Radiotherapy 32fludarabine phosphate 29Gemcitabine 28venetoclax 27atezolizumab 26Paclitaxel 26Ipilimumab 26Radiation 22Dexamethasone 22Cisplatin 22Radiosurgery 21durvalumab 20Rituximab 20Lenalidomide 19Temozolomide 17Bevacizumab 17Pemetrexed 15Decitabine 15Cytarabine 15130-nm albumin-bound paclitaxel 15palbociclib 14ibrutinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Photons × Clear all
NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03587038 2025-12-10

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

University of Oklahoma

Phase 1 Active not recruiting
27 enrolled
CNS

Glioblastoma

NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡